Art House

For more than 40 years, Art House has been working with businesses of all types as a corporate lawyer and litigator. He chairs the firm’s Science & Technology and Alternative Dispute Resolution practice groups, and is a member of the Corporate practice group with an emphasis on partnering strategies, and mergers and acquisitions. Art brings responsiveness and an ability to offer practical solutions to his clients, understanding that his clients’ business needs drive the deals, not the lawyer.

Art’s background in enterprise development, licensing for technology-based companies and assisting both established and start-up businesses in developing legal, business alliance and acquisition strategies gives him unique insight into the real-world problems facing business owners. He advises his clients on a number of matters including legal and regulatory compliance for information security, the negotiation and preparation of licensing and co-venture agreements, software and hardware industry agreements, and corporate mergers and acquisitions.

His services to clients cover a wide range of industry challenges, including pharmaceutical and biotech licensing, software and hardware development and licensing, SaaS, privacy and identity theft protection and remediation, the transfer and protection of intellectual property, equipment manufacturing, supply-chain controls and distribution, and systems integration for ISPs, ASPs, manufacturers, information technology, video gaming, biotechnology, medical device, telephony and cable TV companies.

As one of the leading Alternative Dispute Resolution attorneys in the Mid-Atlantic region, Art is a member of both the American Arbitration Association’s Panel of Neutrals (Commercial Arbitration) and Panel of Mediators, and is a mediator of the International Mediation Institute (IMI), located in The Hague, Netherlands. He has been chosen to serve on numerous arbitration cases as arbitration panel chair, panel arbitrator, and sole arbitrator in matters involving pharmaceuticals, drug development, robotics, software development, licensing, franchising, FDA, FIFRA, insurance coverage, mergers and acquisitions, and other contractual and commercial disputes, both domestic and international. Art has been designated by the American Arbitration Association to serve on “Large, Complex Cases” and also hears international cases for the International Centre for Dispute Resolution.

Outside of his practice, Art is an Adjunct Assistant Professor at Georgetown University’s School of Medicine, lecturing on intellectual property, business formation, licensing and entrepreneurship in the University’s Masters Degree Program in Biotechnology and Microbiology. He has also been a frequent guest speaker at the University of Maryland’s R.H. Smith Business School and at Virginia Commonwealth University